Deluxe Corp.

Print is now ~53% of revenue as payments and data grow, and FY25 comparable adjusted EPS hit $3.61.

If you own DLX, the check-and-forms print line is still the largest slice, but no longer a majority of sales.

dlx

financials small cap updated mar 27, 2026
$23.55
market cap ~$1B · 52-week range $14–$24
xvary composite: 65 / 100 · average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Deluxe helps businesses move money and still sells checks, forms, promos, and data tools.
how it gets paid
FY2025 revenue was $2.13B (+0.5% vs. prior year). Print revenue was $1.14B, about 53% of sales.
why it's growing
Comparable adjusted revenue rose 1.1%; comparable adjusted diluted EPS was $3.61 (+10.7% vs. prior year). GAAP diluted EPS was $1.80 (+52.5% vs. prior year).
what just happened
Q4 2025 revenue was $535.3M (+2.8% vs. prior year). Comparable adjusted EPS was $0.89 (+6% vs. prior year); GAAP diluted EPS was $0.26 (down from $0.28 vs. prior year).
At a glance
B balance sheet — gets the job done, barely
10/100 earnings predictability — expect surprises
~6.5x trailing on comparable adjusted EPS ($3.61 FY25) — low multiple on the metric management emphasizes
5.1% dividend yield — cash in your pocket every quarter
~12% return on equity FY25 — improved with higher net income, still not elite
xvary composite: 65/100 — average
What they do
Deluxe helps businesses move money and still sells checks, forms, promos, and data tools.
In FY2025, Print was 53.3% of revenue ($1.14B). Merchant Services was 18.7% ($0.40B), B2B Payments 13.6% ($0.29B), and Data Solutions 14.4% ($0.31B). Checks and forms still matter, but payments and data are a larger combined piece than a few years ago.
financials small-cap payments dividend data
How they make money
$2.13B annual revenue · reported revenue grew +0.5% last year (comparable adjusted +1.1%)
Print
$1.14B
down
Merchant Services
$0.40B
up
B2B Payments
$0.29B
flat
Data Solutions
$0.31B
up
The products that matter
payments and data services
Payments & Data Services
part of a $2.13B revenue base
management frames Deluxe as a payments and data company; segment reporting still splits print, merchant, B2B payments, and data. FY25 revenue grew 0.5% reported and 1.1% on a comparable adjusted basis.
core story
services for banks
Financial Institution Services
within the same $2.13B total
banks and FIs are embedded across merchant, payments, and data lines; the filing gives segment revenue and adjusted EBITDA for those four buckets, not a standalone “FI services” P&L.
relationship business
services for consumer brands
Consumer Brand Services
also inside $2.13B revenue
consumer-facing programs sit across segments; use the four revenue lines in “how they make money” as the filing-backed view.
less disclosed
Key numbers
+23%
upside to target
The $29 target sits 23% above $23.55, so you are not paying for a moonshot.
5.1%
dividend yield
You get paid ~5% while waiting; the board set a $0.30 quarterly dividend (Feb 2026 press release).
20.2%
comparable adj. EBITDA margin
FY2025 comparable adjusted EBITDA was $431.5M on $2.13B revenue — the metric management uses for operating leverage.
$1.39B
net debt
Net debt was ~$1.39B at Dec 31, 2025; total debt less cash — leverage matters if EBITDA slips.
Financial health
B
strength
  • balance sheet grade B — adequate — nothing special
  • risk rank 3 — safer than 50% of stocks
  • price stability 45 / 100
  • long-term debt ~$1.41B long-term debt + $16M current portion (Dec 31, 2025)
  • net profit margin 3.9% — keeps about 4 cents of every dollar in revenue (GAAP net margin FY25)
  • return on equity 12% — net income vs year-end shareholders’ equity FY25
B — functional but not a standout on the balance sheet.
Total return vs. market

You invested $10,000 in DLX 3 years ago → it's now worth $14,550.

The index would have given you $14,770.

source: institutional data · total return
What just happened
beat on adjusted
Q4 2025 revenue $535.3M (+2.8% vs. prior year); comparable adjusted EPS $0.89 (+6% vs. prior year).
GAAP diluted EPS was $0.26 (down from $0.28 vs. prior year) after impairments and restructuring noise — the filing separates that from comparable adjusted EPS, which is what most screens compare to consensus.
$535M
Q4 revenue
$0.89
adj. EPS
$3.61
FY adj. EPS
the number that mattered
FY2025 comparable adjusted diluted EPS of $3.61 (+10.7% vs. prior year) and free cash flow of $175.3M — both in the Jan 28, 2026 release.
source: Deluxe Form 8-K/A exhibit 99.1, Jan 28, 2026 (reported results)

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is stalled revenue while carrying ~$1.4B of net debt.

med
growth stalls out again
DLX produced $2.13B in revenue last year (+0.5% reported, +1.1% comparable adjusted). If growth stalls against a leveraged balance sheet, the equity story thins out.
when a company grows this slowly, the multiple usually stays low — even next to a low comparable adjusted P/E.
med
leverage limits flexibility
~$1.43B total debt and ~$1.39B net debt (year-end 2025) sit against a ~3.9% GAAP net margin — little room for a prolonged EBITDA miss.
if cash generation softens, debt service competes with dividends, buybacks, and reinvestment. you do not get many free options here.
med
earnings can swing on you
earnings predictability is 10/100. In plain english: the path is noisy, which makes it harder to trust a low multiple at face value.
GAAP EPS can diverge from adjusted EPS quarter to quarter (Q4 GAAP $0.26 vs comparable adjusted $0.89) — read both lines.
combined, these risks point to the same issue: low single-digit revenue growth, ~$1.4B net debt, and a sub-4% GAAP net margin leave little cushion.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
top-line growth above flat
$2.13B of annual revenue grew 0.5% reported and 1.1% comparable adjusted — the stock does not need hypergrowth, but it does need the payments/data mix to keep offsetting print decline.
risk
debt versus flexibility
track net debt (~$1.39B) and free cash flow (~$175M FY25, ~$200M guided for 2026) against dividends and deleveraging.
earnings
does FY26 guidance land
management guided adjusted EPS $3.90–$4.30 and EBITDA $445M–$470M — execution against that range is the clean 2026 scorecard.
trend
institutional interest with conviction
net buying for two quarters is useful, but 98 buyers versus 92 sellers is a nudge, not a stampede.
Analyst rankings
short-term outlook
top 5%
momentum score 1 — analysts expect above-average performance in the near term. in human-speak, they think the setup looks better than the business quality does.
risk profile
average
stability score 3 — neither especially safe nor unusually dangerous. middle of the pack is still not a compliment when leverage is this visible.
chart momentum
average
technical score 3 — the stock is not breaking away from the market. the chart is behaving, not shouting.
earnings predictability
10 / 100
earnings predictability is weak. you should assume a bumpier reporting pattern than the low p/e makes it seem.
source: institutional data
Institutional activity

institutions have been net buying for 2 consecutive quarters — 98 buyers vs. 92 sellers in 3q2025. total institutional holdings: 38.4M shares. net buying for 2 quarters.

source: institutional data
Price targets
3-5 year target range
$16 $42
$23.55 current price
$29 target midpoint · +23% from current · 3-5yr high: $50 (+110% · 23% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
DLX
xvary deep dive
dlx
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it